Course Leader

Michael Childress
Michael Childress
DVM, MS, DACVIM (Onc)
Associate Professor of Comparative Oncology
Purdue University
Dr. Michael Childress received his DVM degree in 2004 from the Virginia-Maryland Regional College of Veterinary Medicine. Subsequently, he completed a rotating internship at Kansas State University and an oncology internship at the University of Georgia, before completing a 3-year residency/master’s degree program in comparative oncology at Purdue from 2006-2009. He joined the faculty of the Purdue College of Veterinary Medicine in 2009, where he is currently an associate professor of comparative oncology and head of the medical oncology section. His research focuses on the study of naturally-occurring canine lymphomas as a transnational model for non-Hodgkin lymphomas in humans.

Speakers

Matthew Atherton
Matthew Atherton
BVCs, MVM, PhD, DipECVIM-CA (onc), MRCVS
University of Pennsylvania
Dr. Matt Atherton completed veterinary school at the University of Bristol. Following three years in mixed practice Matt undertook a rotating internship at the Royal Veterinary College. Matt gained board certification in medical oncology following residency training at the University of Glasgow and was awarded Master of Veterinary Medicine for researching the canine serum proteome. Subsequently he defended his PhD at McMaster University with data from this research enabling “first-in-man” oncolytic virotherapy trials. Matt is currently the Shuman Translational Research Fellow at Penn Vet where his clinical work and research focuses on cellular immunotherapy for canine cancer patients.

Anne Avery
Anne Avery
DVM, PhD
Professor
Colorado State University
Dr. Anne Avery completed her PhD in Immunology at Cornell University, and veterinary school at the University of Pennsylvania where she graduated in 1990. After an internship in small animal medicine at Penn, she did her post-doctoral training at the Dana-Farber Cancer Institute in Boston. She moved to CSU’s college of Veterinary Medicine in 1994 and is now Associate Professor in the Department of Microbiology, Immunology and Pathology, and Director of the Clinical Immunology Laboratory. The goals of the laboratory are to provide clinically relevant diagnostic information about lymphoproliferative disorders, and to conduct research on the biology of these diseases.

Antonella Borgatti
Antonella Borgatti
DVM, MS, DACVIM, DECVIM
Assistant Clinical Professor of Oncology
University of Minnesota
Dr. Antonella Borgatti completed her DVM from the University of Torino, Italy. She pursued specialized training in oncology at North Carolina State University where she subsequently remained as a Research Associate, Oncology Intern, and Clinical Instructor in Oncology. She completed a Residency in Comparative Oncology at Purdue University where she also received a Master of Sciences Degree in 2006.

Dr. Borgatti joined the faculty at the University of Minnesota in 2008. The main focus of her research has been to develop alternative, targeted, biological drugs against chemotherapy refractory solid tumors in companion animals and evaluate their translational potential and applicability for treatment of human disease.

Erin Dickerson
Erin Dickerson
PhD
Associate Professor
University of Minnesota
Dr. Erin Dickerson received her PhD in biochemistry from the University of Wisconsin-Madison in 1997. She then spent several years at the School of Veterinary Medicine in Madison and the Georgia Institute of Technology developing targeted drug approaches to treat cancer. Dr. Dickerson returned to the upper Midwest in 2009 and joined the faculty at the University of Minnesota and the Masonic Cancer Center. She has developed a research program devoted to studying canine hemangiosarcoma, and her group is working on new approaches to treat this disease.

Amanda Guth
Amanda Guth
DVM, PhD
Assistant Professor
Colorado State University
Dr. Amanda Guth is an assistant professor in the Department of Clinical Sciences at Colorado State University. After earning her DVM from Colorado State University, she started a post-doc position studying tumor immunology that led to her present day interest in understanding the immune response to tumors.

Dr. Guth’s current interests lie in combining novel ways to block immune-inhibitory cells to enhance the effects of tumor vaccines and other immunotherapies. She has recently been focusing on developing vaccines targeting cancer stem cells and studying a novel method for generating whole cell, autologous tumor vaccines, both in mouse models and in client-owned dogs.

Matti Kiupel
Matti Kiupel
DVM, Dr. Vet. Med., Dr Habil, MVSC, Phd, DACVP
Professor
Michigan State University
Dr. Matti Kiupel is an anatomic pathologist and professor in the Department of Pathobiology and Diagnostic Investigation and the Veterinary Diagnostic Laboratory at Michigan State University. He oversees the histology and immunohistochemistry laboratory, the largest veterinary diagnostic molecular pathology laboratory in the country. He has published more than 300 peer-reviewed papers and numerous book chapters in veterinary and comparative pathology, specifically tumorpathology, and is the editor of the “Surgical Pathology of Tumors in Domestic Animals” (former WHO fascicles) series.

Amy LeBlanc
Amy LeBlanc
DVM, DACVIM
Director, Comparative Oncology Program
National Cancer Institute
Dr. Amy LeBlanc is the Director of the intramural National Cancer Institute’s Comparative Oncology Program. She conducts preclinical mouse and translational canine studies designed to inform the drug and imaging agent development path for human cancer patients; these studies evaluate immunotherapeutics, targeted small molecules, oncolytic viruses, medical devices, and cancer imaging agents. She directly oversees the NCI Comparative Oncology Trials Consortium (COTC), which provides infrastructure necessary to connect participating veterinary academic institutions with stakeholders in drug development to execute fit-for-purpose comparative clinical trials.

Steven Suter
Steven Suter
VMD, MS, PhD, DACVIM
Director of the Canine Bone Marrow Transplant Unit and Director of the Canine/Feline Oncology Diagnostic Laboratory
North Carolina State University
Dr. Steven Suter earned his VMD and PhD at the University of Pennsylvania and completed a medical oncology residency at UC Davis. Dr. Suter then joined the faculty at North Carolina State University in 2005 and is currently the Medical Director of the Canine Bone Marrow Transplant Unit and the Director of the Canine/Feline Oncology Diagnostic Laboratory. In addition, he helps run a very busy Medical Oncology service that diagnoses and treats companion animals with a wide variety of malignancies. His professional life is a marriage of both bench science and clinical practice, with many opportunities for overlap.

Douglas Thamm
Douglas Thamm
VMD, DACVIM
Barbra Cox Anthony Professor and Director of Clinical Research
Colorado State University
Dr. Douglass Thamm received his VMD degree from the University of Pennsylvania. He completed an Oncology Residency at the University of Wisconsin, and was a researcher there for 5 additional years before joining the faculty at CSU in 2004. He has authored over 140 peer-reviewed publications and 20 book chapters in veterinary and basic cancer research, was Oncology Section Editor for the 2 most recent editions of Kirk’s Current Veterinary Therapy and is Co-Editor-In-Chief of the journal Veterinary and Comparative Oncology.

David Vail
David Vail
DVM, MS, DACVIM
Professor
University of Wisconsin
Dr. David Vail received his DVM from the University of Saskatchewan in 1984 and completed an internship in small animal medicine and surgery at Colorado State University prior to practicing in his native western Canada for two years. He completed a residency in Medical Oncology at the Animal Cancer Center at Colorado State University in 1990. Dr. Vail has served as President of the Veterinary Cancer Society, Chairman of the Scientific Advisory Boards for the Morris Animal Foundation and the ACVIM Foundation, President of the Canine Comparative Oncology and Genomics Consortium (CCOGC), and past North American journal editor for Veterinary and Comparative Oncology. He is a founding member of the Comparative Oncology Trials consortium.